Niagen Bioscience (NAGE) EBT Growth (3y) (2014 - 2026)
Niagen Bioscience (NAGE) EBT Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
75.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
75.68% |
| Dec 31, 2025 |
71.72% |
| Sep 30, 2025 |
52.74% |
| Jun 30, 2025 |
37.23% |
| Mar 31, 2025 |
38.83% |
| Dec 31, 2024 |
50.45% |
| Sep 30, 2024 |
30.30% |
| Jun 30, 2024 |
86.08% |
| Mar 31, 2024 |
59.45% |
| Dec 31, 2023 |
26.38% |
| Sep 30, 2023 |
38.95% |
| Jun 30, 2023 |
16.11% |
| Mar 31, 2023 |
30.61% |
| Dec 31, 2022 |
45.38% |
| Sep 30, 2022 |
24.74% |
| Jun 30, 2022 |
6.22% |
| Mar 31, 2022 |
2.58% |
| Dec 31, 2021 |
13.54% |
| Sep 30, 2021 |
-0.96% |
| Jun 30, 2021 |
11.40% |
